|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$7.63 |
$7.73 |
$7.53 |
$7.60 |
3.61M | 04/19/2024 |
$7.58 |
$7.94 |
$7.55 |
$7.92 |
2.53M | 04/22/2024 |
$8.00 |
$8.19 |
$7.90 |
$8.06 |
2.77M | 04/23/2024 |
$8.07 |
$8.35 |
$8.06 |
$8.31 |
2.54M | 04/24/2024 |
$8.24 |
$8.36 |
$8.09 |
$8.10 |
1.85M |
|
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing the treatment of GI diseases. Co. is focused on the development and commercialization of GI product opportunities. LINZESS® (linaclotide), Co.'s commercial product, is a product approved by the U.S. Food and Drug Administration in a class of GI medicines called guanylate cyclase type C agonists and is indicated for adult suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation. Co. is also developing IW-3300, a GC-C agonist, for the potential treatment of visceral pain conditions, including interstitial cystitis / bladder pain syndrome and endometriosis. | |
|
Ironwood Pharmaceuticals (IRWD) has the following price history information. Looking back at IRWD historical stock prices for the last five trading days, on April 18, 2024, IRWD opened at $7.63, traded as high as $7.73 and as low as $7.53, and closed at $7.60. Trading volume was a total of 3.61M shares. On April 19, 2024, IRWD opened at $7.58, traded as high as $7.94 and as low as $7.55, and closed at $7.92. Trading volume was a total of 2.53M shares. On April 22, 2024, IRWD opened at $8.00, traded as high as $8.19 and as low as $7.90, and closed at $8.06. Trading volume was a total of 2.77M shares. On April 23, 2024, IRWD opened at $8.07, traded as high as $8.35 and as low as $8.06, and closed at $8.31. Trading volume was a total of 2.54M shares. On April 24, 2024, IRWD opened at $8.24, traded as high as $8.36 and as low as $8.09, and closed at $8.10. Trading volume was a total of 1.85M shares.
IRWD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ironwood Pharmaceuticals shares, starting with a $10,000 purchase of IRWD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$8.52 |
|
End price/share: |
$8.10 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-4.93% |
|
Average Annual Total Return: |
-0.50% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,511.23 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $7.60 | 04/19/2024 | $7.92 | 04/22/2024 | $8.06 | 04/23/2024 | $8.31 | 04/24/2024 | $8.10 |
|
|